Literature DB >> 14715251

ATBF1 enhances the suppression of STAT3 signaling by interaction with PIAS3.

Shunsuke Nojiri1, Takashi Joh, Yutaka Miura, Nobuo Sakata, Tomoyuki Nomura, Haruhisa Nakao, Satoshi Sobue, Hirotaka Ohara, Kiyofumi Asai, Makoto Ito.   

Abstract

ATBF1 was first discovered as a suppressor of AFP expression in hepatocytes. It is present in brain, adult liver, lung, and gastro-intestinal tract. Recently, it has been reported that ATBF1 regulates myoblastic differentiation and interacts with v-Myb in regulation of its transactivation. Using the yeast two-hybrid system, we searched for protein-protein interactions to uncover new functions for ATBF1. We present here experimental evidence that ATBF1 is a new regulatory factor for STAT3-mediated signal transduction through its interaction with PIAS3. PIAS3 was thus identified as an ATBF1-binding protein. In co-transfection experiments, the full-length ATBF1 was found to form complexes with PIAS3 in Hep G2 cells. In the luciferase assay, ATBF1 was found to have no influence on STAT3 signaling induced by IL-6 stimulation, but it did synergistically enhance PIAS3 inhibition of activated STAT3. In conclusion, ATBF1 can suppress the IL-6-mediated cellular response by acting together with PIAS3.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14715251     DOI: 10.1016/j.bbrc.2003.12.054

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  29 in total

1.  Cooperative interaction between protein inhibitor of activated signal transducer and activator of transcription-3 with epidermal growth factor receptor blockade in lung cancer.

Authors:  Amy Kluge; Snehal Dabir; Jeffrey Kern; David Nethery; Balazs Halmos; Patrick Ma; Afshin Dowlati
Journal:  Int J Cancer       Date:  2009-10-01       Impact factor: 7.396

2.  Estrogen up-regulates ATBF1 transcription but causes its protein degradation in estrogen receptor-alpha-positive breast cancer cells.

Authors:  Xue-Yuan Dong; Peng Guo; Xiaodong Sun; Qunna Li; Jin-Tang Dong
Journal:  J Biol Chem       Date:  2011-03-02       Impact factor: 5.157

3.  Significant association of SNP rs2106261 in the ZFHX3 gene with atrial fibrillation in a Chinese Han GeneID population.

Authors:  Cong Li; Fan Wang; Yanzong Yang; Fenfen Fu; Chengqi Xu; Lisong Shi; Sisi Li; Yunlong Xia; Gang Wu; Xiang Cheng; Hui Liu; Chuchu Wang; Pengyun Wang; Jianjun Hao; Yuhe Ke; Yuanyuan Zhao; Mugen Liu; Rongfeng Zhang; Lianjun Gao; Bo Yu; Qiutang Zeng; Yuhua Liao; Bo Yang; Xin Tu; Qing K Wang
Journal:  Hum Genet       Date:  2010-11-25       Impact factor: 4.132

Review 4.  The role of transcription factors in atrial fibrillation.

Authors:  Mengchen Zhou; Yuhua Liao; Xin Tu
Journal:  J Thorac Dis       Date:  2015-02       Impact factor: 2.895

5.  SUMOylation of the transcription factor ZFHX3 at Lys-2806 requires SAE1, UBC9, and PIAS2 and enhances its stability and function in cell proliferation.

Authors:  Rui Wu; Jiali Fang; Mingcheng Liu; Jun A; Jinming Liu; Wenxuan Chen; Juan Li; Gui Ma; Zhiqian Zhang; Baotong Zhang; Liya Fu; Jin-Tang Dong
Journal:  J Biol Chem       Date:  2020-04-05       Impact factor: 5.157

6.  Novel association of polymorphic genetic variants with predictors of outcome of catheter ablation in atrial fibrillation: new directions from a prospective study (DECAF).

Authors:  Sanghamitra Mohanty; Amelia W Hall; Prasant Mohanty; Sameer Prakash; Chintan Trivedi; Luigi Di Biase; Pasquale Santangeli; Rong Bai; J David Burkhardt; G Joseph Gallinghouse; Rodney Horton; Javier E Sanchez; Patrick M Hranitzky; Amin Al-Ahmad; Vishwanath R Iyer; Andrea Natale
Journal:  J Interv Card Electrophysiol       Date:  2016-01       Impact factor: 1.900

7.  Patterns of CTCF and ZFHX3 Mutation and Associated Outcomes in Endometrial Cancer.

Authors:  Christopher J Walker; Mario A Miranda; Matthew J O'Hern; Joseph P McElroy; Kevin R Coombes; Ralf Bundschuh; David E Cohn; David G Mutch; Paul J Goodfellow
Journal:  J Natl Cancer Inst       Date:  2015-09-01       Impact factor: 13.506

8.  Interruption of nuclear localization of ATBF1 during the histopathologic progression of head and neck squamous cell carcinoma.

Authors:  Xiaodong Sun; Jie Li; Gabriel Sica; Song-Qing Fan; Yuxiang Wang; Zhengjia Chen; Susan Muller; Zhuo Georgia Chen; Xiaoying Fu; Xue-Yuan Dong; Peng Guo; Dong M Shin; Jin-Tang Dong
Journal:  Head Neck       Date:  2012-07-13       Impact factor: 3.147

9.  Genetic polymorphisms confer risk of atrial fibrillation in patients with heart failure: a population-based study.

Authors:  J Gustav Smith; Olle Melander; Marketa Sjögren; Bo Hedblad; Gunnar Engström; Christopher Newton-Cheh; Pyotr G Platonov
Journal:  Eur J Heart Fail       Date:  2012-11-06       Impact factor: 15.534

10.  A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease.

Authors:  David Burgner; Sonia Davila; Willemijn B Breunis; Sarah B Ng; Yi Li; Carine Bonnard; Ling Ling; Victoria J Wright; Anbupalam Thalamuthu; Miranda Odam; Chisato Shimizu; Jane C Burns; Michael Levin; Taco W Kuijpers; Martin L Hibberd
Journal:  PLoS Genet       Date:  2009-01-09       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.